David Park '19, Author at DARTMOUTH BUSINESS JOURNAL

When Two and Two Come Together: Personalization in Business Models

At the Dartmouth Entrepreneurs Forum on April 1, 2016, dozens of students, aspiring entrepreneurs and interested individuals attended informative workshops and sought out the advice of esteemed speakers. Among the speakers were Amanda Reed, a general partner at Palomar Ventures,... Continue reading...

Markets

Sustained Growth and R&D: The Pharmaceutical Industry’s Divide

Nearly two years since AstraZeneca shafted Pfizer’s $104-billion courtship offer, Pfizer and Allergan announced on Nov. 23, 2015 that they were going to merge with a $160-billion mega-deal – the largest deal in the pharmaceutical industry’s history. After the deal... Continue reading...

Government

The Pharmaceutical Price Gouging Dilemma

Drugs play a critical role in our daily lives – they can be used to reduce pain, regulate bodily processes, and even mitigate metastasizing of cancer. Since pharmaceutical drugs are essential to the health of American citizens, the public reacts... Continue reading...

DARTMOUTH BUSINESS JOURNAL

When Two and Two Come Together: Personalization in Business Models

Sustained Growth and R&D: The Pharmaceutical Industry’s Divide

The Pharmaceutical Price Gouging Dilemma

Popular

Foreign Direct Investment in Nigeria

Singapore’s Market-Model Healthcare System

The Smartwatch – the Next “It” Item?

Automation: The End of the Middle Class?

South America’s Newest Trade Bloc and America

Syrian Refugees: From Burden to Benefit

Random

What Now? A Post Steve Jobs World

Cutco: Schemers or Success Story?

The New Tax Dodge

From the Dot Com Bubble to the Tech Boom

The Chinese Boom and Bust

David and Goliath: Is Fintech a Threat to the Financial Behemoths?